ThermoGenesis Holdings Inc (OTCPK:THMO)
$ 0.211 -0.009 (-4.09%) Market Cap: 1.68 Mil Enterprise Value: 7.50 Mil PE Ratio: 0 PB Ratio: 1.76 GF Score: 32/100

Thermogenesis Holdings Inc at H C Wainwright Global Investment Conference (Virtual) Transcript

Sep 14, 2022 / 04:00PM GMT
Release Date Price: $9.48 (-7.91%)
Unidentified Analyst

Hi, everyone. Thank you for joining us for our next session, on day three of our healthcare conference at HCW. I'm pleased to announce ThermoGenesis Holdings will be here and been speaking about their company. We have Chris Xu with us, CEO. This is a company that has been around for two decades or so, leading developments of cell and gene therapy and transforming basically a medical device company into optimizing how these therapies are given. And there's a strategic update today that we'll be hearing more about. And if there's time afterwards, we can have some Q&A. Go ahead; thank you.

Chris Xu
ThermoGenesis Holdings, Inc. - Chairman and CEO

Hi, everybody. I'm Chris Xu, the Chairman and CEO of ThermoGenesis Holdings, Inc. We are a NASDAQ listed, small-size public company.

So just a reminder, this presentation do contain forward-looking statement that's regulated and there by the SEC and NASDAQ. So for our company, we have been around for many decades. So the company originally was founded in 1986 as a medical device company. And over

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot